Ipriflavone as an inhibitor of human cytochrome P450 enzymes

British Journal of Pharmacology

Volumn 123, Issue 4, 1998, Pages 605-610

  Monostory, Katalin ^a   Vereczkey, László ^a   Lévai, Ferenc ^b   Szatmári, István ^b  

^a CTRL RES INSTITUTE FOR CHEMISTRY   (Hungary)

^b Chinoin Pharmaceutical and Chemical Works Ltd   (Hungary)

Author keywords

Human cytochrome P450 enzymes; Inhibition; Ipriflavone

Indexed keywords

CYP3A PROTEIN, HUMAN; CYTOCHROME P450; ENZYME INHIBITOR; IPRIFLAVONE; ISOENZYME; ISOFLAVONE DERIVATIVE;

ARTICLE; BLOOD; CLINICAL TRIAL; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; HUMAN; KINETICS; LIVER MICROSOME;

CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INHIBITORS; HUMANS; ISOENZYMES; ISOFLAVONES; KINETICS; MICROSOMES, LIVER;

EID: 0031989335     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701633     Document Type: Article

References (21)

1. BEYELER, S., TESTA, B. & PERRISSOUD, D. (1988). Flavonoids as inhibitors of rat liver monooxygenase activities. Biochem. Pharmacol., 37, 1971 - 1979.
2. BRIAN, W.R., SRIVASTAVA, P.K., UMBENHAUER, D.R., LLOYD, R.S. & GUENGERICH, F.P. (1989). Expression of a human liver cytochrome P-450 protein with tolbutamide hydroxylase activity in Saccharomyces cerevsiae. Biochemistry, 28, 4993 - 4999.
3. BUTLER, M.A., GUENGERICH, F.P. & KADLUBAR, F.F. (1989a). Metabolic oxidation of the carcinogens 4-aminobiphenyl and 4,4′-methylene-bis(2-chloroaniline) by human hepatic microsomes and by purified rat hepatic cytochrome P-450 monooxygenases. Cancer Res., 49, 25 - 31.
4. PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc. Natl. Acad. Sci. U.S.A., 86, 7696 - 7700.
5. GUENGERICH, F.P., MARTIN, V.M., BEAUNE, P.H., KREMERS, P., WOLFF, T. & WAXMAN, D.J. (1986). Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. J. Biol. Chem., 261, 5051 - 5060.
6. VAN DER HOEVEN, T.A. & COON, M.J. (1974). Preparation and properties of partially purified cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase from rabbit liver microsomes. J. Biol Chem., 249, 6302 - 6310.
7. KNODELL, R.G., HALL, S.D., WILKINSON, G.R & GUENGERICH, F.P. (1987). Hepatic metabolism of tolbutamide: characterization of the form of cytochrome P-450 involved in methyl hydroxylation and relationship to in vivo disposition. J. Pharmacal. Exp. Ther., 241, 1112 - 1119.
8. KRONBACH, T., MATHYS, D., GUT, J., CATIN, T. & MEYER, U.A. (1987). High-performance liquid Chromatographic assays for bufuralol 1′-hydroxylase, debrisoquine 4-hydroxylase and dextromethorphan O-demethylase in microsomes and purified cytochrome P-450 isozymes of human liver. Anal. Biochem., 162, 24 - 32.
9. LOWRY, H., ROSEBROUGH, N.J., FARR, A.L & RANDALL, R.J. (1951). Protein measurement with Folin phenol reagent. J. Biol. Chem., 193, 265 - 275.
10. MERKEL, U. & HOFFMANN, A. (1996). Inhibition of 7-ethoxyresorufin-deethylase in mouse and human liver microsomes by flavonoids. Exp. Toxic. Pathol., 48/ Suppl II, 274 - 280.
11. MONOSTORY, K. & VERECZKEY, L. (1995). Interaction of theophylline and ipriflavone at cytochrome P450 level. Eur. J. Drug Metab. Pharmacokin., 20, 43 - 47.
12. MONOSTORY, K. & VERECZKEY, L. (1996). The effect of ipriflavone and its main metabolites on theophylline biotransformation. Eur. J. Drug Metab. Pharmacokin., 21, 61 - 66.
13. PETER, R., BÖCKER, R., BEAUNE, P.H., IWASAKI, M., GUENGERICH, F.P. & YANG, C.S. (1990). Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1. Chem. Res. Toxicol., 3, 566 - 573.
14. RAUNIO, H., SYNGELMA, T. PASANEN, M., JUVONEN, R., HONKAKOSKI, P., KAIRALUOMA, M.A., SOTANIEMI, E., LANG, M.A. & PELKONEN, O. (1988). Immunochemical and catalytical studies on hepatic coumarin 7-hydroxylase in man, rat, and mouse. Biochem. Pharmacol., 37, 3889 - 3895.
15. RETTIE, A.E., KORZEKWA, K.R., KUNZE, K.L., LAWRENCE, R.F., EDDYLL, A.C., AOYAMA, T., GELBOIN, H.V., GONZALEZ, F.J. & TRAGER, W.F. (1992). Hydroxylation of warfarin by human liver cytochrome P-450: a role for proteins encoded by CYP2C9 in the etiology of (S)-warfarin-drug interactions. Chem. Res. Toxicol., 5, 54 - 59.
16. ROBSON, R.A., MINERS, J.O., MATTHEWS, A.P., STUPANS, I., MELLER, D., MCMANUS, M.E. & BIRKETT, D.J. (1988). Characterisation of theophylline metabolism by human liver microsomes. Biochem. Pharmacol., 37, 1651 - 1659.
17. SARKAR, M.A., HUNT, C., GUZELIAN, P.S. & KARNES, H.T (1992). Characterization of human liver cytochrome P-450 involved in theophylline metabolism. Drug Metab. Dispos., 20, 31 - 37.
18. SRIVASTAVA, P.K., YUN, C.-H., BEAUNE, P.M., GED, C. & GUENGERICH, F.P. (1991). Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4′-hydroxylase cytochrome P-450 enzymes. Mol. Pharmacol., 40, 69 - 79.
19. TAKAHASHI, J., KAWAKATSU, K., WAKAYAMA, T. & SAWAOKA, H. (1992). Elevation of serum theophylline levels by ipriflavone in a patient with chronic obstructive pulmonary disease. Eur. J. Clin. Pharmacol., 43, 207 - 208.
20. VERONESE, M.E., MACKENZIE, P.I., DOECKE, C.J., MCMANUS, M.E., MINERS, J.O. & BIRKETT, D.J. (1991). Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cytochrome P4502C9. Biochem. Biophys. Res. Commun., 175, 1112 - 1118.
21. YAMAZAKI, I. & KINOSHITA, M. (1986). Calcium secreting property of ipriflavone in the presence of estrogen. Life Sci., 38, 1535 - 1541.